- Home
- COCH vs CODX Comparison
COCH vs CODX Comparison
Compare COCH & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- CODX
- Stock Information
- Founded
- COCH 1995
- CODX 2013
- Country
- COCH United States
- CODX United States
- Employees
- COCH N/A
- CODX N/A
- Industry
- COCH Blank Checks
- CODX Medical/Dental Instruments
- Sector
- COCH Finance
- CODX Health Care
- Exchange
- COCH Nasdaq
- CODX Nasdaq
- Market Cap
- COCH 19.2M
- CODX 16.9M
- IPO Year
- COCH N/A
- CODX 2017
- Fundamental
- Price
- COCH $0.91
- CODX $0.38
- Analyst Decision
- COCH Strong Buy
- CODX Buy
- Analyst Count
- COCH 2
- CODX 2
- Target Price
- COCH $9.25
- CODX $2.00
- AVG Volume (30 Days)
- COCH 8.4M
- CODX 14.7M
- Earning Date
- COCH 11-13-2025
- CODX 11-06-2025
- Dividend Yield
- COCH N/A
- CODX N/A
- EPS Growth
- COCH N/A
- CODX N/A
- EPS
- COCH N/A
- CODX N/A
- Revenue
- COCH $222,000.00
- CODX $1,003,653.00
- Revenue This Year
- COCH $3.66
- CODX N/A
- Revenue Next Year
- COCH $31.19
- CODX $31.58
- P/E Ratio
- COCH N/A
- CODX N/A
- Revenue Growth
- COCH N/A
- CODX N/A
- 52 Week Low
- COCH $0.74
- CODX $0.23
- 52 Week High
- COCH $3.09
- CODX $1.35
- Technical
- Relative Strength Index (RSI)
- COCH 47.04
- CODX 51.77
- Support Level
- COCH $0.87
- CODX $0.37
- Resistance Level
- COCH $1.02
- CODX $0.44
- Average True Range (ATR)
- COCH 0.11
- CODX 0.04
- MACD
- COCH 0.03
- CODX -0.00
- Stochastic Oscillator
- COCH 19.16
- CODX 52.07
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.